Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2012
09/27/2012US20120244069 Human monoclonal antibodies against cd25
09/27/2012CA2830882A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
09/27/2012CA2830792A1 Neuroprotective peptides
09/27/2012CA2830788A1 Methods and compositions for treatment of attention deficit disorder
09/27/2012CA2830519A1 Myelin regeneration with androgens
09/27/2012CA2830515A1 6-substituted estradiol derivatives for use in remyelination of nerve axons
09/27/2012CA2830511A1 Pharmaceutical compositions comprising a water-insoluble antipsychotic and sorbitan esters
09/27/2012CA2830458A1 Combinations of alpha 7 nicotinic acetylcholine receptor activators and mglur5 antagonists for use in dopamine induced dyskinesia in parkinson's disease
09/27/2012CA2830259A1 Peptides for suppressing inflammation
09/27/2012CA2829690A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same
09/27/2012CA2829687A1 New crystalline form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
09/27/2012CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012CA2822783A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/26/2012EP2502999A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
09/26/2012EP2502933A2 Method for preparing gintonin, which is a novel glycolipoprotein from panax ginseng, and gintonin, which is a novel glycolipoprotein, prepared by the method
09/26/2012EP2502921A1 Arylsulfonamide CCR3 antagonists
09/26/2012EP2502918A1 Pyridizinone Derivatives
09/26/2012EP2502917A1 Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole
09/26/2012EP2502914A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502912A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502911A2 Modulators of ATP-binding cassette transporters
09/26/2012EP2502909A1 Aminopyridine derivative
09/26/2012EP2502619A2 Systems and methods for delivery of materials
09/26/2012EP2501706A1 A novel 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2h-thiazolo [4,5-di pyrimidin-6-yl - and process for preparation thereof
09/26/2012EP2501704A1 Spiropiperidine compounds as orl-1 receptor antagonists
09/26/2012EP2501703A1 Spiropiperidine compounds as orl-1 receptor antagonists
09/26/2012EP2501697A1 Benzoimidazole compounds and uses thereof
09/26/2012EP2501669A2 Novel arylated camphenes, processes for their preparation and uses thereof
09/26/2012EP2501372A2 Intravenous infusion of curcumin and a calcium channel blocker
09/26/2012EP2501234A1 Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
09/26/2012CN1950342B Novel compounds as opioid receptor modulators
09/26/2012CN1947717B Method for treating neuronal and non-neuronal pain
09/26/2012CN1764462B T-type calcium channel blockers
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN102695723A Improved neurturin molecules
09/26/2012CN102695722A Antibodies and epitopes specific to misfolded prion protein
09/26/2012CN102695709A Crystalline forms of substituted pyrazolopyrimidines
09/26/2012CN102695701A MGLU2 agonists
09/26/2012CN102695546A Heterocylcic derivatives as inhibitors of glutaminyl cyclase
09/26/2012CN102695545A Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
09/26/2012CN102695502A Compositions for treating drug addiction and improving addiction-related behavior
09/26/2012CN102690346A Polypeptide treating diabetes, its preparation method and application
09/26/2012CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors
09/26/2012CN102690265A 4-substituted azaadamantane derivatives and methods of use thereof
09/26/2012CN102690259A Compound with function of diuresis, preparation method and functions thereof
09/26/2012CN102690244A Substances regulating alpha-synuclein accumulation and its pharmaceutical application
09/26/2012CN102690238A Synthesis of barbituric acid derivative as RSK2 inhibitor and application thereof
09/26/2012CN102690231A Method for synthesizing potential drug of Semagacestat for treating Alzheimer disease
09/26/2012CN102690221A 改性的拟赖氨酸化合物 Proposed modification of lysine compound
09/26/2012CN102690210A Novel crystal form VII of agomelatine, preparation method and application thereof and pharmaceutical composition containing the same
09/26/2012CN102690209A Mixed crystal of agomelatine (form-VIII), preparation method and application thereof and pharmaceutical composition containing the same
09/26/2012CN102688501A Proanthocyanidin B2 phospholipid compound, and preparation method and application thereof
09/26/2012CN102688483A Composition for treating dermatosis, preparation containing composition and preparation method thereof
09/26/2012CN102688461A Medicament treating epilepsy and its preparation method
09/26/2012CN102688454A Medicinal composition for treating Alzheimer disease, as well as preparation method and application thereof
09/26/2012CN102688416A Nutritional health-care product for improving agrypnia
09/26/2012CN102688399A Mother chrysanthemum traditional Chinese medicine oral liquid for treating dizziness and preparation method for oral liquid
09/26/2012CN102688390A Chinese medicinal composition for treating epilepsy and preparation method thereof
09/26/2012CN102688378A Traditional Chinese medicine oral liquid for relieving insomnia and preparation method for oral liquid
09/26/2012CN102688362A Medicine composition for treating epilepsy by combined treatment of traditional Chinese medicine and western medicine
09/26/2012CN102688353A Traditional Chinese medicine for treating insomnia
09/26/2012CN102688335A Chinese medicine composition for treating wind-heat type common cold and preparation method of Chinese medicine composition
09/26/2012CN102688262A Nutritional health-care product for improving depression
09/26/2012CN102688247A Application of nestorone to preparation of drugs for treating Parkinson's disease
09/26/2012CN102688243A Clathrate compound of perphenazine cyclodextrin derivative, and preparation method thereof
09/26/2012CN102688234A Synthesis of indolone derivative as RSK2 inhibitor and application
09/26/2012CN102688233A Synthesis of benzotriazol derivative as RSK2 inhibitor and application thereof
09/26/2012CN102688232A Synthesis and application of isoindole-1, 3-dione derivative as RSK2 inhibitor
09/26/2012CN102688230A New applciation of procyanidine B2
09/26/2012CN102688226A Medicinal composition
09/26/2012CN102688216A Gabapentin tablet and preparation method thereof
09/26/2012CN102688214A Preparation method of levetiracetam sustained release tablet
09/26/2012CN102688213A Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
09/26/2012CN102688210A Lurasidone medicine composition and preparation method
09/26/2012CN102688209A Lurasidone tablet and preparation method thereof
09/26/2012CN102688189A Lurasidone medicine composition and preparation method thereof
09/26/2012CN102688186A Medicine composition containing vinpocetine raw material
09/26/2012CN102274425B Chinese medicinal composition for improving sleep quality
09/26/2012CN102228452B Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof
09/26/2012CN102225131B Traditional Chinese medicine for resisting viruses
09/26/2012CN102144970B Alprostadil lipid nanosphere injection and preparation method thereof
09/26/2012CN102078299B Citicoline sodium liposome solid preparation
09/26/2012CN102014931B Use and preparation of paeoniflorin and the composition thereof
09/26/2012CN102000127B Preparation method of chimonanthus inhibited acetylcholinesterase active part and application thereof
09/26/2012CN101974089B Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection
09/26/2012CN101838269B 1,3,8-triaza-spiro[4.5]decane-4-ketone compounds and pharmaceutical application thereof
09/26/2012CN101791340B Method for purifying active ingredients of compound Naodesheng
09/26/2012CN101732251B Oxiracetam liposome injection
09/26/2012CN101621999B Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
09/26/2012CN101600433B Agent for prophylaxis or treatment of substance abuse and dependence
09/26/2012CN101420943B Chewing composition containing coenzyme q10
09/26/2012CN101406500B Medicament for treating headache and migraine, and preparation method thereof
09/26/2012CN101371843B Use of loxapine and amoxapine for the preparation of a medicament for the treatment of pain
09/26/2012CN101264277B Compound essential oil for controlling smoke and giving up smoking
09/26/2012CN101128484B Compositions and methods relating to anti IGF-1 receptor antibodies
09/25/2012US8273916 Crystal comprising (2R)-2-propyloctanoic acid and amine
09/25/2012US8273895 NK1 antagonists
09/25/2012US8273855 Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system
09/25/2012US8273765 Bicyclo-pyrazoles and pharmaceutical compositions comprising them
09/25/2012US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation